ARQT logo

Arcutis Biotherapeutics, Inc. (ARQT) Free cash flow

annual FCF:

-$117.30M+$130.18M(+52.60%)
December 31, 2024

Summary

  • As of today (September 3, 2025), ARQT annual free cash flow is -$117.30 million, with the most recent change of +$130.18 million (+52.60%) on December 31, 2024.
  • During the last 3 years, ARQT annual FCF has risen by +$58.32 million (+33.21%).
  • ARQT annual FCF is now -3007.31% below its all-time high of -$3.77 million, reached on December 31, 2017.

Performance

ARQT Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

quarterly FCF:

-$9.75M+$21.23M(+68.52%)
June 30, 2025

Summary

  • As of today (September 3, 2025), ARQT quarterly free cash flow is -$9.75 million, with the most recent change of +$21.23 million (+68.52%) on June 30, 2025.
  • Over the past year, ARQT quarterly FCF has increased by +$35.37 million (+78.38%).
  • ARQT quarterly FCF is now -69.69% below its all-time high of -$5.75 million, reached on December 31, 2024.

Performance

ARQT quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

TTM FCF:

-$81.32M+$35.37M(+30.31%)
June 30, 2025

Summary

  • As of today (September 3, 2025), ARQT TTM free cash flow is -$81.32 million, with the most recent change of +$35.37 million (+30.31%) on June 30, 2025.
  • Over the past year, ARQT TTM FCF has increased by +$95.70 million (+54.06%).
  • ARQT TTM FCF is now -1292.96% below its all-time high of -$5.84 million, reached on December 31, 2018.

Performance

ARQT TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

ARQT Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+52.6%+78.4%+54.1%
3 y3 years+33.2%+84.3%+61.7%
5 y5 years-172.0%+62.2%-7.1%

ARQT Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+58.3%-69.7%+87.9%at high+72.3%
5 y5-year-172.0%+58.3%-69.7%+87.9%-7.1%+72.3%
alltimeall time-3007.3%+58.3%-69.7%+87.9%-1293.0%+72.3%

ARQT Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$9.75M(-68.5%)
-$81.32M(-30.3%)
Mar 2025
-
-$30.99M(+439.1%)
-$116.69M(-0.5%)
Dec 2024
-$117.30M(-52.6%)
-$5.75M(-83.5%)
-$117.30M(-30.1%)
Sep 2024
-
-$34.83M(-22.8%)
-$167.80M(-5.2%)
Jun 2024
-
-$45.12M(+42.8%)
-$177.02M(-10.9%)
Mar 2024
-
-$31.60M(-43.8%)
-$198.66M(-19.7%)
Dec 2023
-$247.49M(-11.9%)
-$56.25M(+27.7%)
-$247.49M(-5.7%)
Sep 2023
-
-$44.05M(-34.0%)
-$262.42M(-10.6%)
Jun 2023
-
-$66.76M(-17.0%)
-$293.58M(+1.6%)
Mar 2023
-
-$80.43M(+13.0%)
-$288.88M(+8.8%)
Dec 2022
-$281.00M(+60.0%)
-$71.19M(-5.3%)
-$265.55M(+7.8%)
Sep 2022
-
-$75.20M(+21.2%)
-$246.33M(+16.1%)
Jun 2022
-
-$62.06M(+8.7%)
-$212.15M(+14.1%)
Mar 2022
-
-$57.10M(+9.9%)
-$185.96M(+5.9%)
DateAnnualQuarterlyTTM
Dec 2021
-$175.62M(+54.9%)
-$51.97M(+26.7%)
-$175.62M(+12.6%)
Sep 2021
-
-$41.02M(+14.3%)
-$155.91M(+4.5%)
Jun 2021
-
-$35.87M(-23.3%)
-$149.16M(+7.3%)
Mar 2021
-
-$46.76M(+45.0%)
-$139.06M(+22.7%)
Dec 2020
-$113.35M(+162.8%)
-$32.25M(-5.9%)
-$113.35M(+14.2%)
Sep 2020
-
-$34.27M(+33.0%)
-$99.26M(+30.7%)
Jun 2020
-
-$25.78M(+22.5%)
-$75.93M(+30.2%)
Mar 2020
-
-$21.05M(+15.9%)
-$58.33M(+31.0%)
Dec 2019
-$43.13M(+206.2%)
-$18.16M(+65.8%)
-$44.53M(+38.2%)
Sep 2019
-
-$10.95M(+34.0%)
-$32.21M(+51.5%)
Jun 2019
-
-$8.17M(+12.6%)
-$21.27M(+62.4%)
Mar 2019
-
-$7.26M(+24.3%)
-$13.10M(+124.3%)
Dec 2018
-$14.09M(+273.1%)
-$5.84M
-$5.84M
Dec 2017
-$3.77M
-
-

FAQ

  • What is Arcutis Biotherapeutics, Inc. annual free cash flow?
  • What is the all time high annual FCF for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. annual FCF year-on-year change?
  • What is Arcutis Biotherapeutics, Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. quarterly FCF year-on-year change?
  • What is Arcutis Biotherapeutics, Inc. TTM free cash flow?
  • What is the all time high TTM FCF for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. TTM FCF year-on-year change?

What is Arcutis Biotherapeutics, Inc. annual free cash flow?

The current annual FCF of ARQT is -$117.30M

What is the all time high annual FCF for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high annual free cash flow is -$3.77M

What is Arcutis Biotherapeutics, Inc. annual FCF year-on-year change?

Over the past year, ARQT annual free cash flow has changed by +$130.18M (+52.60%)

What is Arcutis Biotherapeutics, Inc. quarterly free cash flow?

The current quarterly FCF of ARQT is -$9.75M

What is the all time high quarterly FCF for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high quarterly free cash flow is -$5.75M

What is Arcutis Biotherapeutics, Inc. quarterly FCF year-on-year change?

Over the past year, ARQT quarterly free cash flow has changed by +$35.37M (+78.38%)

What is Arcutis Biotherapeutics, Inc. TTM free cash flow?

The current TTM FCF of ARQT is -$81.32M

What is the all time high TTM FCF for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high TTM free cash flow is -$5.84M

What is Arcutis Biotherapeutics, Inc. TTM FCF year-on-year change?

Over the past year, ARQT TTM free cash flow has changed by +$95.70M (+54.06%)
On this page